Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0450
+0.0050 (12.50%)
Oct 30, 2026, 3:49 PM EDT
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 15.28 million as of October 30, 2026. It is the 40,880th most valuable company in the world and the 1,388th biggest in Canada. Its market cap has increased by 41.75% in one year.
Market Cap
15.28M
Enterprise Value
11.73M
Revenue
n/a
Global Rank
Country Rank
#1,388 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 17.41M to 15.28M, a decrease of -12.25%. That is a compound annual growth rate of -1.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 18.68M | 54.00% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 26.53M |
| Resverlogix | 25.82M |
| Telescope Innovations | 23.84M |
| The More Life Company | 20.57M |
| Onco-Innovations | 19.38M |
| Devonian Health Group | 18.77M |
| Pharmala Biotech Holdings | 17.55M |
| Rapid Dose Therapeutics | 13.78M |